Press release
Newly Released Visiongain Report: Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029
Your guide to your industry
To find out more about the report, click the link:
https://www.visiongain.com/report/global-anti-idiopathic-pulmonary-fibrosis-drugs-market-forecast-to-2029/
The global anti-idiopathic pulmonary fibrosis drugs market is expected to grow at a CAGR of 16.7% in the first half of the forecast period. In 2018, the anti-fibrotics held the largest market share (51%) followed by the tyrosine kinase inhibitors.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 171-page report you will receive 69 tables and 97 figures– all unavailable elsewhere.
The 171-page report provides clear detailed insight into the global anti-idiopathic pulmonary fibrosis drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Anti-Idiopathic Pulmonary Fibrosis Drugs market forecasts to 2029
• This report also breaks down the revenue forecast for the global anti-idiopathic pulmonary fibrosis drugs market by mechanism of action:
• Antifibrotics
• Tyrosine Kinase Inhibitors
• Anti-inflammatory Drugs
• Immunosuppressants
• Other MoA
Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029
• This report also breaks down the revenue forecast for the global anti-idiopathic pulmonary fibrosis drugs market by Innovator and Off-label drugs:
• Innovator Drugs
• Off-label Drugs
• This report provides individual revenue forecasts to 2029 for these national markets:
• US
• Japan
• EU5: Germany, France, the UK, Italy, Spain
• Rest of World
• This report provides individual revenue forecasts to 2029 for these marketed drugs:
• Esbriet
• Ofev
• Our study gives qualitative analysis of the anti-idiopathic pulmonary fibrosis drugs market. It discusses:
• Diagnosed Prevalence of Idiopathic Pulmonary Fibrosis in the G7 markets
• Epidemiology of Idiopathic Pulmonary Fibrosis by disease severity
• Epidemiology of Idiopathic Pulmonary Fibrosis by gender
• Discussion on novel clinical molecules under development for the treatment of Idiopathic Pulmonary Fibrosis
• Pricing and Reimbursement Overview on Ofev and Esbriet (by NICE, SMC, PBAC, CADTH, G-BA, HAS)
• A SWOT Analysis on the anti-idiopathic pulmonary fibrosis drugs market
• Our study discusses the marketed anti-idiopathic pulmonary fibrosis drugs and pipeline anti-idiopathic pulmonary fibrosis drugs from these companies:
• Actelion
• Afferent Pharmaceuticals
• Asahi Kasei Pharma
• Bellerophon Therapeutics
• Biogen
• Boehringer Ingelheim
• FibroGen
• Galapagos
• Galecto Biotech
• Genentech
• Global Blood Therapeutics
• GSK
• Kadmon Pharmaceuticals
• LTT Bio-Pharma
• MediciNova
• Merck
• Moerae
• Pacific Therapeutics
• Promedior
• ProMetic Life Sciences
• Roche
• Sanofi
• Teva
• Zai Lab
Visiongain’s study is intended for anyone requiring commercial analyses for the global Anti-Idiopathic Pulmonary Fibrosis Drugs Market. You find data, trends and predictions.
Buy our report today Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029: Antifibrotics, Tyrosine Kinase Inhibitors, Anti-inflammatory Drugs, Immunosuppressants, Other MoA, Innovator Drugs.
Related Reports:
Needles Market Report 2020-2030:
https://www.visiongain.com/report/needles-market-report-2020-2030/
Medical Cyclotron Market Report 2020-2030:
https://www.visiongain.com/report/medical-cyclotron-market-report-2020-2030/
Medical Document Management Systems Market Report 2020-2030:
https://www.visiongain.com/report/medical-document-management-systems-market-report-2020-2030/
For more Pharma reports, visit our website:
https://www.visiongain.com/industries/pharma/
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Visiongain Limited
Airport House
Purley Way
Surrey
London
CR0 0XZ
United Kingdom
About Visiongain:
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Newly Released Visiongain Report: Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029 here
News-ID: 1875758 • Views: …
More Releases from visiongain
Can Coatings Market Research Report Up to 2031
Visiongain has published a new report on Can Coatings Market Report to 2031: Segmentation by Type (Epoxy, Oleoresin, Vinyl, Phenolic, Acrylic, Polyester, Polyolefin, Additives, Other Type) Segmentation by Coating Technologies (Conventional solvent borne coatings, High-solids coatings, Waterborne coatings, Ultraviolet radiation-cured (UV-cured) coatings, Powder coatings, Other Technologies) Segmentation by Application (Food Can, Beverage Can, General Line Can, Aerosol Can, Others, Other Application) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped,…
Automatic Number Plate Recognition (ANPR) System Market Report Up to 2031
Visiongain has published a new report on Automatic Number Plate Recognition (ANPR) System Market Report to 2031: Forecasts by component (Hardware, Software, Services), by type (Fixed ANPR Systems, Portable ANPR Systems), by application (Traffic Management, Law Enforcement, Electronic Toll Collection, Others). PLUS Profiles of Leading Automatic Number Plate Recognition System Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/anpr-system-market/#download_sampe_div
Automatic number plate…
Automatic Labelling Machine Market Report Up to 2031
Visiongain has published a new report on Automatic Labelling Machine Market Report to 2031: Forecasts by type (Stretch Sleeve Labelers, Shrink-Sleeve Labelers, Glue-based Labelers, Others), by industry vertical (Consumer Goods, Food & Beverages, Automotive, Pharmaceuticals, Others). PLUS Profiles of Leading Automatic Labelling Machine Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/automatic-labelling-machine-market/#download_sampe_div
An automatic labeling machine is designed to print-and-apply labels to…
Atomic Absorption Spectrometer Market Report Up to 2031
Visiongain has published a new report on Atomic Absorption Spectrometer Market Report to 2031: Forecasts by type (Х-rау Dіffrасtіоn Ѕресtrоmеtrу, Х-rау Fluоrеѕсеnсе Ѕресtrоmеtrу, Others), by application (Рhаrmасеutісаl, Mining Industry, Petrochemical Industry, Fооd & Веvеrаgе, Others). PLUS Profiles of Leading Atomic Absorption Spectrometer Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/atomic-absorption-spectrometer-market/#download_sampe_div
Atomic absorption spectrometer is the determination of elemental composition and is…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
